Jennifer B. Rose

1.3k total citations
19 papers, 784 citations indexed

About

Jennifer B. Rose is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jennifer B. Rose has authored 19 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Jennifer B. Rose's work include Adenosine and Purinergic Signaling (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Jennifer B. Rose is often cited by papers focused on Adenosine and Purinergic Signaling (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Jennifer B. Rose collaborates with scholars based in Canada, United States and United Kingdom. Jennifer B. Rose's co-authors include Earl D. Silverman, Brian M. Feldman, Rotraud K. Saurenmann, Rayfel Schneider, Pascal N. Tyrrell, Ronald M. Laxer, Alex V. Levin, Imogen R. Coe, R M Laxer and Zlatina Naydenova and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Oncology and Life Sciences.

In The Last Decade

Jennifer B. Rose

19 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer B. Rose Canada 11 401 296 276 182 125 19 784
Marina Mesquida Spain 19 193 0.5× 1.1k 3.6× 405 1.5× 129 0.7× 8 0.1× 33 1.2k
Alex Fonollosa Spain 20 145 0.4× 1.1k 3.9× 207 0.8× 163 0.9× 12 0.1× 71 1.4k
Simona Ursu United Kingdom 14 425 1.1× 13 0.0× 212 0.8× 296 1.6× 38 0.3× 23 1.2k
Rossella Franceschini Italy 20 145 0.4× 851 2.9× 504 1.8× 194 1.1× 10 0.1× 48 1.1k
Sarah L. N. Clarke United Kingdom 10 188 0.5× 150 0.5× 112 0.4× 315 1.7× 1 0.0× 23 649
Merih Soylu Türkiye 14 47 0.1× 721 2.4× 133 0.5× 140 0.8× 14 0.1× 33 949
Ryoji Yamakawa Japan 14 26 0.1× 427 1.4× 75 0.3× 148 0.8× 6 0.0× 54 679
O Hübscher Argentina 14 108 0.3× 14 0.0× 257 0.9× 117 0.6× 4 0.0× 30 756
Sibel Kadayıfçılar Türkiye 18 75 0.2× 738 2.5× 214 0.8× 119 0.7× 4 0.0× 77 975
Charles Masson France 14 268 0.7× 10 0.0× 289 1.0× 85 0.5× 3 0.0× 24 754

Countries citing papers authored by Jennifer B. Rose

Since Specialization
Citations

This map shows the geographic impact of Jennifer B. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer B. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer B. Rose more than expected).

Fields of papers citing papers by Jennifer B. Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer B. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer B. Rose. The network helps show where Jennifer B. Rose may publish in the future.

Co-authorship network of co-authors of Jennifer B. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer B. Rose. A scholar is included among the top collaborators of Jennifer B. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer B. Rose. Jennifer B. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Viteri, Santiago, Anna Minchom, Lyudmila Bazhenova, et al.. (2022). Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real‐world genomic datasets. Molecular Oncology. 17(2). 230–237. 18 indexed citations
3.
4.
Viteri, Santiago, Joshua Bauml, Lyudmila Bazhenova, et al.. (2021). 1P Real-world frequency of non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutations by site of insertion. Journal of Thoracic Oncology. 16(4). S699–S699. 3 indexed citations
5.
6.
Woo, Vincent, Alan Bell, Maureen Clement, et al.. (2019). CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice. Canadian Journal of Diabetes. 43(7). 464–471. 4 indexed citations
7.
Woo, Vincent, Alan Bell, Maureen Clement, et al.. (2018). CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice. Diabetes Obesity and Metabolism. 21(3). 691–699. 9 indexed citations
8.
9.
Rose, Jennifer B., Zlatina Naydenova, Andrew Bang, et al.. (2011). Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge. Life Sciences. 89(17-18). 621–630. 32 indexed citations
10.
Rose, Jennifer B., et al.. (2010). Nucleoside transporter expression profiles in human cardiac tissue show striking individual variability with overall predominance of hENT1. European Journal of Pharmaceutical Sciences. 41(5). 685–691. 5 indexed citations
11.
Reyes, German, Zlatina Naydenova, Parween Abdulla, et al.. (2010). Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry. Protein Expression and Purification. 73(1). 1–9. 4 indexed citations
12.
Rose, Jennifer B., Lynda Ellis, Lorraine Martin, et al.. (2009). Does the Macroduct® collection system reliably define sweat chloride concentration in subjects with intermediate results?. Clinical Biochemistry. 42(12). 1260–1264. 10 indexed citations
13.
Rose, Jennifer B., Zlatina Naydenova, Andrew Bang, et al.. (2009). Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection. American Journal of Physiology-Heart and Circulatory Physiology. 298(3). H771–H777. 58 indexed citations
14.
Naydenova, Zlatina, Jennifer B. Rose, & Imogen R. Coe. (2008). Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line. American Journal of Physiology-Heart and Circulatory Physiology. 294(6). H2687–H2692. 15 indexed citations
15.
Rose, Jennifer B. & Imogen R. Coe. (2008). Physiology of Nucleoside Transporters: Back to the Future. . . .. Physiology. 23(1). 41–48. 38 indexed citations
16.
Saurenmann, Rotraud K., Alex V. Levin, Brian M. Feldman, et al.. (2007). Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: A long‐term followup study. Arthritis & Rheumatism. 56(2). 647–657. 184 indexed citations
17.
Saurenmann, Rotraud K., Jennifer B. Rose, Pascal N. Tyrrell, et al.. (2007). Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: Ethnicity as a risk factor. Arthritis & Rheumatism. 56(6). 1974–1984. 182 indexed citations
18.
Saurenmann, Rotraud K., Alex V. Levin, Jennifer B. Rose, et al.. (2006). Tumour necrosis factor α inhibitors in the treatment of childhood uveitis. Lara D. Veeken. 45(8). 982–989. 151 indexed citations
19.
Callaghan, Judy M., et al.. (1992). The mouse gastric H,K-ATPase beta subunit. Gene structure and co-ordinate expression with the alpha subunit during ontogeny.. Journal of Biological Chemistry. 267(2). 1165–1174. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Mesquida Breakdown of academic impact, for papers by Alex Fonollosa Breakdown of academic impact, for papers by Simona Ursu Breakdown of academic impact, for papers by Rossella Franceschini Breakdown of academic impact, for papers by Sarah L. N. Clarke Breakdown of academic impact, for papers by Merih Soylu Breakdown of academic impact, for papers by Ryoji Yamakawa Breakdown of academic impact, for papers by O Hübscher Breakdown of academic impact, for papers by Sibel Kadayıfçılar Breakdown of academic impact, for papers by Charles Masson
Rankless by CCL
2026